V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210035152 | 210013797 | 0 | 96.1 | Curative (C) | null | 2018-05-19 | PACLITAXEL | N | N | 210029239 | CLARITY TRIAL |
| 210035153 | 210013801 | null | 53.5 | Curative (C) | 2019-06-24 | 2019-10-02 | Enzalutamide | N | N | 210029407 | DHAP |
| 210035154 | 210013804 | 1.71 | 88.4 | Curative (C) | 2016-02-06 | 2016-11-13 | DOXORUBICIN | N | N | 210029552 | TRASTUZUMAB |
| 210035155 | 210013807 | 0.85 | 91.2 | Curative (C) | 2015-12-16 | 2016-01-14 | Irinotecan + Temozolomide | Y | null | 210029666 | CLARITY TRIAL |
| 210035156 | 210022624 | 1.73 | 0 | Curative (C) | 2019-02-25 | 2019-04-03 | MERCAPTOPURINE + METHOTREXATE + VINCRISTINE | N | N | 210030225 | CARFILZOMIB |
| 210035157 | 210022628 | 1.63 | 49 | null | 2018-12-27 | 2019-04-24 | CLL210 TRIAL | Y | N | 210030551 | BEAM |
| 210035158 | 210013836 | 0 | 87.4 | Palliative (P) | 2017-10-26 | 2018-02-02 | Packer Maintenance Regimen | N | N | 210031093 | ABVD |
| 210035159 | 210013841 | 1.54 | 34 | Palliative (P) | 2017-07-30 | 2017-07-30 | Oxaliplatin + Modified de Gramont | Y | N | 210031205 | IMMUNOGLOBULIN |
| 210035160 | 210013844 | 1.53 | 89.6 | Palliative (P) | 2018-10-12 | 2018-11-04 | CYTARABINE + ETOPOSIDE | N | N | 210031222 | DOXORUBICIN |
| 210035161 | 210013851 | 1.7 | null | Palliative (P) | 2017-06-12 | 2017-06-12 | CNS LGG Irinotecan & Bevacizumab | N | N | 210031639 | CYTARABINE + RITUXIMAB |
| 210035162 | 210028214 | null | 93 | Curative (C) | 2018-09-03 | 2018-09-07 | IDARUBICIN | 02 | N | 210032710 | ABVD |
| 210035163 | 210013881 | 1.66 | 68.2 | Palliative (P) | null | 2017-11-01 | FLUDARABINE | N | N | 210033322 | UKALL 60+ TRIAL |
| 210035164 | 210013900 | 1.46 | 59 | Palliative (P) | 2019-03-03 | 2019-03-03 | FLUDARABINE | N | N | 210033837 | IMMUNOGLOBULIN |
| 210035165 | 210028225 | 1.75 | 99.2 | Curative (C) | 2020-04-21 | 2020-04-28 | Cytarabine intrathecal | Y | N | 210034315 | OFATUMUMAB |
| 210035166 | 210022683 | 1.63 | 17.5 | null | 2019-11-30 | 2019-11-30 | PACLITAXEL | 02 | N | 210034391 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 210035167 | 210013931 | null | 50 | Curative (C) | 2018-02-15 | 2018-09-16 | FLAG | N | null | 210035201 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE |
| 210035168 | 210013941 | 1.68 | 66.7 | null | 2016-06-22 | 2016-07-26 | Irinotecan + Modified De Gramont | N | N | 210035533 | ALL MAINTENANCE |
| 210035169 | 210013952 | 1.67 | 82.3 | Curative (C) | 2018-02-17 | 2018-02-17 | CYTARABINE + ETOPOSIDE | 2 | Y | 210036454 | UKALL 60+ TRIAL |
| 210035170 | 210013960 | 1.7 | 76.1 | Curative (C) | 2019-10-07 | 2020-04-14 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | 02 | N | 210036496 | PEMETREXED |
| 210035171 | 210022719 | null | 64 | Adjuvant (A) | 2018-11-18 | 2019-06-07 | Packer Maintenance Regimen | N | null | 210037672 | NHL 2003 |
| 210035172 | 210013982 | 1.58 | 95.5 | Curative (C) | 2020-03-18 | 2020-03-21 | DASATINIB + IDARUBICIN + VINCRISTINE | N | N | 210037675 | CYTARABINE |
| 210035173 | 210013989 | 0 | 54 | Adjuvant (A) | 2018-08-12 | 2018-08-12 | Carboplatin + Pemetrexed | 2 | N | 210038079 | CYTARABINE |
| 210035174 | 210013995 | 1.79 | 47 | Curative (C) | 2018-09-22 | 2018-09-22 | CARBOPLATIN + ETOPOSIDE + VINCRISTINE SULPHATE | N | N | 210038641 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 210035175 | 210028255 | null | 95 | Disease modification (D) | 2015-03-04 | 2015-03-04 | Lenalidomide 25mg (Cycle 1 to 25) | N | null | 210039506 | PENTOSTATIN + RITUXIMAB |
| 210035176 | 210014015 | 0 | 16.2 | Curative (C) | 2015-04-07 | 2018-03-03 | Cisplatin + Vinorelbine (IV) | 2 | N | 210040040 | ALL |
| 210035177 | 210014036 | 0 | 68 | Curative (C) | 2017-10-23 | 2018-01-15 | TAVAREC | N | Y | 210041159 | CLL210 TRIAL |
| 210035178 | 210014041 | 1.57 | 82.3 | Curative (C) | 2017-05-02 | 2017-06-14 | CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE | N | N | 210041453 | MITOMYCIN INTRAVESICULAR |
| 210035179 | 210014047 | null | null | Disease modification (D) | 2020-02-03 | 2020-02-06 | Alemtuzumab + Cyclophos TBI Allo | N | null | 210041755 | IDARUBICIN |
| 210035180 | 210028266 | 1.56 | 78.6 | Unknown (U) | 2019-01-16 | 2019-01-16 | CARBOPLATIN + VINORELBINE | N | null | 210041781 | ALEMTUZUMAB + CYCLO + FLUDARABINE |
| 210035181 | 210014057 | 1.87 | 13.7 | Disease modification (D) | 2016-04-11 | 2016-04-19 | CISPLATIN + ETOPOSIDE | N | N | 210042047 | OBINUTUZUMAB |
| 210035182 | 210014080 | 1.82 | 69.95 | Curative (C) | 2018-08-10 | 2018-09-08 | Bortezomib + MELPHALAN | 02 | N | 210034307 | DAUNORUBICIN + VNCRISTINE |
| 210035184 | 210032406 | 1.78 | 90.2 | Palliative (P) | 2016-05-14 | 2016-05-14 | TEMOZOLOMIDE | 02 | N | 210000163 | TEMOZOLOMIDE |
| 210035185 | 210004327 | 1.55 | 98 | Disease modification (D) | 2015-03-21 | 2015-05-06 | Temozolomide 200mg/m2 | 2 | N | 210000208 | TEMOZOLOMIDE |
| 210035186 | 210004346 | 1.75 | 92 | Adjuvant (A) | 2013-06-03 | 2014-07-10 | TEMOZOLOMIDE | 02 | N | 210000265 | TEMOZOLOMIDE |
| 210035187 | 210024686 | 1.78 | 98.6 | Adjuvant (A) | 2018-03-30 | 2018-03-31 | Temozolomide 200mg/m2 | 2 | N | 210000286 | TEMOZOLOMIDE |
| 210035188 | 210004377 | 1.74 | 79.1 | Palliative (P) | 2017-10-16 | 2018-03-09 | TEMOZOLOMIDE | N | N | 210000395 | TEMOZOLOMIDE |
| 210035189 | 210032421 | 1.8 | 73.4 | Curative (C) | 2017-02-17 | 2017-08-21 | TEMOZOLOMIDE | N | N | 210000497 | TEMOZOLOMIDE |
| 210035190 | 210004401 | 1.72 | 118.9 | Adjuvant (A) | 2014-05-14 | 2014-05-14 | TEMOZOLOMIDE | 02 | N | 210000561 | TEMOZOLOMIDE |
| 210035191 | 210004406 | 1.7 | null | Curative (C) | null | 2016-11-19 | Temozolomide 200mg/m2 | N | N | 210000602 | TEMOZOLOMIDE |
| 210035192 | 210038311 | null | 89 | Adjuvant (A) | 2017-01-28 | 2017-02-18 | TEMOZOLOMIDE | 02 | N | 210000612 | TEMOZOLOMIDE |
| 210035193 | 210004408 | 1.75 | 79 | Curative (C) | 2016-03-10 | 2016-03-11 | TEMOZOLOMIDE | 02 | N | 210000663 | TEMOZOLOMIDE |
| 210035194 | 210029445 | 1.59 | 88.8 | Adjuvant (A) | 2017-03-04 | 2017-03-04 | TEMOZOLOMIDE | 02 | N | 210000818 | TEMOZOLOMIDE |
| 210035195 | 210024739 | 1.77 | 76.9 | Adjuvant (A) | 2014-05-20 | 2014-08-25 | Temozolomide 200mg/m2 | N | N | 210001063 | TEMOZOLOMIDE |
| 210035196 | 210037751 | 1.7 | 80 | Curative (C) | 2014-10-21 | 2015-03-19 | Temozolomide 200mg/m2 | N | Y | 210001064 | TEMOZOLOMIDE |
| 210035197 | 210024744 | 1.91 | 74.1 | Adjuvant (A) | 2015-10-15 | 2016-05-03 | Temozolomide 200mg/m2 | 02 | null | 210001190 | TEMOZOLOMIDE |
| 210035198 | 210004511 | 1.67 | 46.2 | Palliative (P) | 2018-05-08 | 2019-10-31 | TEMOZOLOMIDE | N | null | 210001305 | TEMOZOLOMIDE |
| 210035199 | 210029475 | 1.6 | 65.8 | Palliative (P) | 2014-09-03 | 2014-09-30 | TEMOZOLOMIDE | N | N | 210001469 | TEMOZOLOMIDE |
| 210035200 | 210032466 | 1.7 | 94.2 | null | 2015-09-21 | 2016-01-18 | TEMOZOLOMIDE | null | null | 210001570 | TEMOZOLOMIDE |
| 210035201 | 210029482 | 1.86 | null | Adjuvant (A) | 2017-08-27 | 2017-11-27 | Temozolomide 200mg/m2 | N | N | 210001572 | TEMOZOLOMIDE |
| 210035202 | 210004563 | 1.62 | 54.9 | Palliative (P) | 2016-07-26 | 2016-08-07 | Temozolomide 200mg/m2 | 02 | N | 210001686 | TEMOZOLOMIDE |